Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)

PHASE2TerminatedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Vasomotor Symptoms (VMS)
Interventions
DRUG

AR08

DRUG

Placebo

Trial Locations (15)

19114

Clinical Research of Philadelphia, LLC, Philadelphia

23502

Tidewater Physicians for Women, Norfolk

27103

Hawthorne Medical Research, Inc., Winston-Salem

33409

Comprehensive Clinical Trials, LLC, West Palm Beach

34748

OB-GYN Associates of Mid-Florida, P.A., Leesburg

37404

Chattanooga Medical Research, LLC, Chattanooga

67226

Cypress Medical Research Center, Wichita

77054

TMC Life Research, Inc., Houston

80906

Clinical Research Advantage, Inc., Colorado Springs

80910

Blue Skies Center for Women, Colorado Springs

89123

Clinical Research Center of Nevada, Las Vegas

92103

Genesis Center for Clinical Research, San Diego

98105

Seattle Womens: Health, Research, Gynecology, Seattle

99461

Altus Research, Lakeworth

08648

Lawrence OB/Gyn Associates, Lawrenceville

Sponsors
All Listed Sponsors
lead

Arbor Pharmaceuticals, Inc.

INDUSTRY

NCT02049164 - Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS) | Biotech Hunter | Biotech Hunter